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Abstract
We studied a family presenting 10 individuals affected by autosomal dominant deafness in all frequencies and three
individuals affected by high frequency hearing loss. Genomic scanning using the 50k Affymetrix microarray technol-
ogy yielded a Lod Score of 2.1 in chromosome 14 and a Lod Score of 1.9 in chromosome 22. Mapping refinement us-
ing microsatellites placed the chromosome 14 candidate region between markers D14S288 and D14S276 (8.85 cM)
and the chromosome 22 near marker D22S283. Exome sequencing identified two candidate variants to explain hear-
ing loss in chromosome 14 [PTGDR – c.G894A:p.R298R and PTGER2 – c.T247G:p.C83G], and one in chromosome
22 [MYH9, c.G2114A:p.R705H]. Pedigree segregation analysis allowed exclusion of the PTGDR and PTGER2 vari-
ants as the cause of deafness. However, the MYH9 variant segregated with the phenotype in all affected members,
except the three individuals with different phenotype. This gene has been previously described as mutated in
autosomal dominant hereditary hearing loss and corresponds to DFNA17. The mutation identified in our study is the
same described in the prior report. Thus, although linkage studies suggested a candidate gene in chromosome 14,
we concluded that the mutation in chromosome 22 better explains the hearing loss phenotype in the Brazilian family.
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Introduction
According to the World Health Organization (WHO)
almost 360 million people of all ages around the world have
disabling hearing loss. Hearing loss can be caused by envi-
ronmental factors, by genetic factors, or both. Hereditary
hearing loss exhibits enormous heterogeneity of inheri-
tance mechanisms, of chromosomal loci and of alleles in
the same locus. Almost 70% of hereditary hearing loss
cases do not display syndromic features (Keats and Berlin,
1999) and are thus called nonsyndromic. On the other hand,
30%, of cases are associated to syndromic features. About
80% of nonsyndromic hereditary hearing loss is due to
autosomal recessive mechanisms (The Connexin Deafness
Homepage), the autosomal dominant mechanism corre-
sponds to 10-20% (Guilford et al., 1994), X-linked inheri-
tance corresponds to 2-3% of the genetic cases of hearing
loss (Van Camp et al., 1997) and the contribution of mater-
nal inheritance was estimated to be near 1%. To date, about
170 loci have been mapped for nonsyndromic hearing loss
and different types of mutations in 75 identified genes have
been found in humans (http://hereditaryhearingloss.org/).
Regarding autosomal dominant hearing loss, about 55 loci
have been mapped and 29 genes have been identified.
Here we report linkage studies and mutation identifi-
cation after massive parallel sequencing of the whole exo-
me in a large Brazilian pedigree with autosomal dominant
hearing loss.
Materials and Methods
Patients
This study was approved by the Comissão Nacional
de Ética em Pesquisa (CONEP; Process number
25000.143724/2003-29). After written informed consent,
samples from 10 individuals affected by postlingual pro-
gressive hearing loss in all frequencies, 10 unaffected indi-
viduals and three individuals affected by high frequency
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hearing loss from the same family were obtained (Figure 1).
The family was ascertained in the city of Porto Alegre, RS,
in southern Brazil. Audiological evaluation of the affected
patients was conducted by different professionals and insti-
tutions.
DNA extraction
DNA was extracted from peripheral blood lympho-
cytes using commercial kits.
Linkage analysis
Genomic scanning was performed using the
Affymetrix technologies SNP array 50k and analyzed with
the softwares Genechip 3000 Scanner and GeneChip Com-
mand Console Software (Affymetrix, Santa Clara, CA,
USA). Fluorescent-labeled microsatellites were analyzed
in an Applied Biosystems 3730 DNA analyzer with the
help of the software GeneMapper 4.0 (Applied Biosystems,
Foster City, CA, USA) for genetic mapping refinement.
Lod score calculations
Merlin software (Abecasis et al., 2002) was used to
calculate multiple point Lod scores for each autosome. The
disease allele frequency was 0.0001 and allelic frequencies
were calculated considering the genotype of the individuals
from the family. Penetrance was assumed to be complete.
Array – CGH (Comparative Genomic Hybridization)
Array-CGH was performed in the index patient using
a platform from Agilent Technologies (Agilent Technol-
ogies, Santa Clara, CA, USA) containing 180.000 oligo-
nucleotides, as described by the manufacturer. Data were
analyzed with Feature Extraction software and Genomic
Workbench software (Agilent Technologies, Santa Clara,
CA, USA). Gains and losses of genomic sequences were
called using an aberration detection statistical algorithm
ADM-2, with a sensitivity threshold of 6.7.
Massive parallel sequencing
DNA samples from three affected individuals were
submitted to whole exome sequencing at Laboratório de
Biotecnologia Animal (ESALQ-USP, Piracicaba, SP, Bra-
zil). Libraries were prepared with an Illumina TruSeq li-
brary preparation kit (Illumina INC., San Diego, CA,
USA.) Sequence capture was performed with Illumina
Exome enrichment kit (~62 Mb target size). Sequencing
was performed with an Illumina HiSeq system with aver-
age read depths of 120x.
Fastq files were aligned to the human reference se-
quence (hg19) with BWA (Burrows-Wheeler Aligner; Li
and Durbin, 2010) for the generation of the BAM files (Bi-
nary Alignment Map). Realignment of indel regions, vari-
ant detection and recalibration of base qualities were
performed with BWA for the production of VCF files
(Variant Call Format). Annotation was performed with
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Figure 1 - Pedigree and haplotype segregation of microsatellites in chromosome 14. Individuals with DNA samples collected are marked with the sym-
bol (-). The proband is indicated by an arrow. Individuals with ? are affected by hearing loss only in high frequencies, with age of onset at 40 years. The
mapped locus based on haplotype segregation is represented in red. Partially striped chromosomes probably resulted from a crossing over event.
Annovar (Wang et al., 2010). Variant frequencies were
compared to the 1000 genomes and ESP6500 databases.
PolyPhen2 (Adzhubei et al., 2010), SIFT (Kumar et al.,
2009) and Mutationtaster (Schwarz et al., 2014) were used
for in silico damage prediction to the protein.
PTGDR, PTGER2 and MYH9 exon analyses by
Sanger sequencing
Primers for amplification of the exons of three candi-
date genes were designed with Primer3. PCR fragments
were purified and directly sequenced in both strands using
the ABI BigDye Terminator v3.1 Cycle Sequencing Kit
and the ABI 3730 DNA Analyzer (Applied Biosystems,
Foster City, CA, USA).
Results
Clinical findings
Hearing loss in this family can be described as pro-
gressive, bilateral, affecting all frequencies, with age of on-
set ranging from 1st to 5th decade of life. Figure 2 presents
the audiogram of six affected individuals, with ages rang-
ing from four to 43 years. Three affected individuals (II:1,
II:5 and II:9) presented a distinct phenotype, since the age
of onset was near 40 and hearing loss affects only high fre-
quencies (audiogram shown in Figure 3) .
Genetic mapping
Genomic scanning was performed with samples of
seven affected individuals (proband, I:1, II:13, II:15, II:17,
III:15, III:17); the three individuals with a distinct pheno-
type were not included. Data from SNP arrays were used in
Lod score calculations. A Lod score peak of 2.1 at chromo-
some 14 and a Lod score peak of 1.9 in a region at chromo-
some 22 were obtained.
Using microsatellite data (Figure 3) obtained from 23
samples (10 affected individuals, 10 unaffected ones and
the three individuals with a different phenotypic presenta-
tion considered as affected), a peak Lod score of 1.8 (Fig-
ure 4) was calculated for chromosome 14. In a second Lod
score calculation, these three individuals were considered
as unaffected and a peak Lod score of 1.5 was obtained.
Regarding chromosome 22, the analysis using micro-
satellite data (Figure 5) from 23 samples (10 affected indi-
viduals, 10 unaffected ones and the three individuals with
different phenotypic presentation considered as affected)
revealed a Lod score of 0.8 (Figure 6). When these three in-
dividuals were considered as unaffected, a peak Lod score
of 3.0 was obtained (Figure 6). A simulation of maximum
possible Lod score in the pedigree was performed using
Merlin, including the same set of samples, this resulting in a
Lod score value of 4.2.
Array-CGH
A DNA sample from one affected individual
(proband) was analyzed by Array-CGH and no pathogenic
copy-number variation was detected.
Massive parallel sequencing
A total of 80.200.676 reads of 99pb each were gener-
ated, presenting an average coverage of 124x. All variants
that were present in heterozygosis in the samples from the
three affected individuals submitted to whole exome se-
quencing and that were not detected in the 17 control sam-
ples sequenced by the same method (controls from our own
research center) were screened for quality and checked
against the 1000 genomes public variant database and the
6500 exomes from Washington University. Only variants
observed with frequencies lower than 1% and located in the
mapped regions were selected for the study. Within the
mapped chromosomal interval in chromosome 14,
(D14S288 to D14S276), two missense variants (not de-
scribed in 1000 genomes) within two genes PTGDR
(c.G894A: p.R298R, position 52,741,496; NM_000953)
and PTGER2 (c.T247G: p.C83G, position 52,781,513;
NM_000956) were found. One variant within the MYH9
gene (c.G2114A:p.R705H, position 36,702,021;
NM_002473) in the candidate chromosome 22 region was
found (linked to D22S283). Polyphen2 predictions indi-
cated a probability of being damaging of 1% for c.G894A
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Figure 2 - Tonal audiometry showing thresholds for six affected individuals.
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Figure 3 - Tonal audiometry showing thresholds for II-V, who presented hearing loss only in high frequencies and with onset near the age of 40.
Figure 4 - Multipoint Lod Scores (on the Y-axis) obtained with microsatellite data for chromosome 14. A) Individuals marked with ? in Figure 1 were
considered unaffected in this calculation; B) Individuals marked with ? in Figure 1 were considered affected by the same genetic disorder in this calcula-
tion.
Figure 5 - Haplotype segregation of microsatellite data for chromosome 22. The proband is indicated by an arrow. Individuals with ? are affected by hear-
ing loss only in high frequencies, with age of onset at 40 years. The mapped locus based on haplotype segregation is represented in red.
in PTGDR, 100% for c.T247G in PTGER2 and 100% for
c.G2114A in MYH9.
The three variants were, thus, selected for segregation
studies. All 23 samples from the pedigree were screened by
Sanger sequencing for the presence of the variants
c.G894A, c.T247G and c.G2114A. The variants in PTGDR
and PTGER2 genes did not segregate with the phenotype,
but the variant in the MYH9 gene did so. The three individu-
als with the different phenotypic presentation carried the
PTGDR and PTGER2 variants, but the MYH9 variant was
not detected in any of their samples.
Discussion
At first, we considered the Lod score peak at chromo-
some 14, which had the highest value, as indicative of the
location of the gene. There are three DFNAs (autosomal
dominant hearing loss loci) already mapped to different re-
gions in chromosome 14. DFNA9 is located at chromo-
somal region 14:31,343,740-31,359,821 and it was mapped
by Manolis et al. (1996). Later on, Robertson et al. (1998)
studied three different families affected by autosomal dom-
inant hearing loss which mapped to DFNA9, and they
found the COCH gene to be associated with hearing loss.
DFNA53 is located at chromosomal region
14:19,100,000-33,300,000 and it was mapped by Yan et al.
(2006). The DFNA53 locus overlaps with DFNA9, but
since the authors were not able to find mutations in the
COCH gene, the locus was considered distinct from DFNA
9. DFNA23 is located in chromosomal region 14:
61,110,132-61,124,977 and it was mapped by Salam et al.
(2000), but the respective gene remains unknown. None of
the three loci overlaps with the region at chromosome 14
mapped in our study, which made us suspect that a new lo-
cus was mapped. However, after segregation studies were
performed with the variants identified after massive paral-
lel exome sequencing, we came to the conclusion that the
mutation that best explains the phenotype lies, in fact, in
chromosome 22, in the MYH9 gene, which corresponds to
DFNA17. This variant is not present in the three individuals
with the distinct phenotype, who were, thus, considered to
be either phenocopies or affected by another type of genetic
hearing loss.
The locus DFNA17 in chromosome 22 has been
mapped by Lalwani et al. (1999), who described a pedigree
from a US family with 18 individuals affected by auto-
somal dominant hearing loss. Age of onset of the hearing
loss was near 10 years. It started at high frequencies, be-
coming moderate to profound near the age of 30 years.
Lalwani et al. (2000) investigated all genes in the DFNA17
locus by Sanger sequencing and identified MYH9 as a novel
deafness gene. The variant c.G2114A (rs80338828), found
by Lawlani et al. (2000), is the same variant we found in our
study. MYH9 is a myosin that functions in actin bundles
motility (Wilson et al., 2010). Hildebrand et al. (2006) in-
vestigated an Australian family presenting autosomal dom-
inant hearing loss, and they found the same variant. The
onset of hearing loss in this family was around the age of
six, becoming severe to profound in the second or third de-
cade of life. The clinical presentation observed in the fam-
ily investigated by us is similar to the phenotype found in
the two previously studied families, except that many of our
patients noticed their hearing impairment around 20 years
of age.
It is intriguing that a strong suggestion of linkage was
also found in chromosome 14 in the first analysis, using
SNP data only. But after microsatellite linkage studies with
more individuals and considering II:1, II:5 and II:9 as unaf-
fected, we realized that the evidence of linkage to chromo-
some 22 was stronger. It is worthy of note that the variants
detected in the genes PTGDR and PTGER2 were found in
the three individuals with different phenotypic presenta-
tion, and they all share a small region on chromosome 14. It
is tempting to speculate that there could be other genetic
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Figure 6 - Multipoint Lod Scores (on the Y-axis) obtained with microsatellite data for chromosome 22. A) Individuals marked with ? in Figure 5 were
considered as unaffected in this calculation; B) Individuals marked with ? in Figure 5 were considered affected by the same genetic disorder in this calcu-
lation.
features in chromosome 14 which could explain the hearing
loss with a less severe phenotype in these individuals. Some
affected individuals in the pedigree inherited both candi-
date haplotypes (in chromosome 14 and 22), but there are
no significant differences in their phenotypes when com-
pared to individuals who inherited only the MYH9 muta-
tion. In fact, a particular allele for D14S275 marker was
inherited by the three individuals with atypical phenotype
and by nine individuals affected by severe hearing loss,
which may have contributed to the high Lod score value ob-
tained for chromosome 14 in this family.
Since the pedigree investigated by us is the third re-
port of variant rs80338828 in the MYH9 gene being associ-
ated to autosomal dominant hearing loss, we came to the
conclusion that this is the most likely cause of the hearing
loss, although a secondary effect of genetic factors lying in
chromosome 14 can not be completely ruled out.
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